Skip to main content
. 2020 Jun 26;319(2):H331–H340. doi: 10.1152/ajpheart.00274.2020

Table 1.

Gravimetric measurements (mass)

n Body, g Heart, mg Left Ventricle, mg Lung, mg Kidney, mg LV/Body, mg/g Lung/Body, mg/g Kidney/Body, mg/g
Control 16 26 ± 1 129 ± 6 87 ± 4 141 ± 4 157 ± 8 3.3 ± 0.1 5.5 ± 0.1 6.0 ± 0.1
Sham 16 24 ± 1 128 ± 6 87 ± 4 134 ± 4 153 ± 7 3.6 ± 0.1 5.7 ± 0.1 6.3 ± 0.2
LVPO, 1 wk 9 26 ± 1 184 ± 16*# 137 ± 12*,# 229 ± 35*# 137 ± 6 6.0 ± 0.6*,# 10.2 ± 1.8*,# 5.3 ± 0.2*,#
LVPO, 4 wk 8 24 ± 1 248 ± 15*# 175 ± 9*,# 372 ± 52*# 138 ± 3 7.4 ± 0.5*,# 15.7 ± 2.3*,# 5.8 ± 0.2
Silica 10 33 ± 1*# 152 ± 6 105 ± 4*,# 248 ± 22*# 183 ± 7*# 3.1 ± 01. 7.3 ± 0.5*,# 5.5 ± 0.1#

Values are means ± SE. LV, left ventricle; LVPO, left ventricular pressure overload.

*

P < 0.05 vs. control;

#

P < 0.05 vs. sham.